What is NCEL's earnings growth forecast for 2025-2025?
(NASDAQ: NCEL) Newcelx's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Newcelx's earnings in 2025 is -$9,335,043.
In 2025, NCEL is forecast to generate -$190,580 in earnings, with the lowest earnings forecast at -$183,106 and the highest earnings forecast at -$196,185.
What is NCEL's revenue growth forecast for 2025-2025?
(NASDAQ: NCEL) Newcelx's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Newcelx's revenue in 2025 is $0.
In 2025, NCEL is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is NCEL's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: NCEL) forecast ROA is -4.39%, which is lower than the forecast US Biotechnology industry average of 8.22%.
What is NCEL's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: NCEL) Newcelx's current Earnings Per Share (EPS) is -$8.20. In 2025, NCEL's EPS is forecast to hit -$0.46 (min: -$0.44, max: -$0.47).
What is NCEL's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: NCEL) forecast ROE is -6.61%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.